The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The Contribution of Local Tissue Thyroxine Monodeiodination to the Nuclear 3,5,3′- Triiodothyronine in Pituitary, Liver, and Kidney of Euthyroid Rats*
Abstract
The contributions of local T4 monodeiodination and plasma T3 to the nuclear T3 of anterior pituitary, liver, and kidney were measured in euthyroid rats. After injection of [125I]T4, there was a gradual increase in the quantity of plasma [125I]T3 in excess of injected contaminant, which peaked at approximately 12 h after injection and remained a constant fraction of plasma [125I]T4 (2.8 X 10(-3) after that time. In the nuclei of anterior pituitary tissue, there was also a slow increase in locally produced [125I]T3 (in excess of that which could be accounted for by plasma [125I]T3) which appeared to peak at about 16 h after [125I]T4 administration. The ratio of nuclear [125I]T3 generated intracellularly to plasma [125I]T4 was constant at 18 and 24 h after T4 injection and was 13 +/- 2 X 10(-3) in nuclei of pituitary, 2.0 +/- 0.4 x 10(-3) in liver, and 0.47 +/- 0.1 x 10(-3) in kidney (all values are mean +/- SD). This locally generated T3 resulted in a markedly higher nuclear to plasma (N:P) ratio for [125I]T3 than for injected [131I]T3 in the same animals. The N:P ratio for [125I]T3 at equilibrium after injected T4 was 2.4 +/- 0.6, 0.47 +/- 0.09, and 0.10 +/- 0.03 (nanograms of T3 (mg DNA)-1/ng T3 ml-1) in pituitary, liver, and kidney. Comparable values for [131I]T3 N:P ratios were 0.47 +/- 0.14 (pituitary), 0.18 +/- 0.01 (liver), and 0.036 +/- 0.008 (kidney). Using RIA values for plasma T4 and T3 concentrations in these rats and maximal nuclear T3-binding capacities estimated in parallel experiments, the gravimetric quantities of nuclear T3 derived from plasma T3 and from local T4 to T3 monodeiodination were estimated and expressed as the percentage of saturation of T3 receptors. Seventy-eight percent of nuclear T3 receptor sites in anterior pituitary were occupied with one-half of the nuclear T3 derived directly from plasma T3 and the other half from intrapituitary T4 monodeiodination. Local T4 monodeiodination provided only 28% and 14%, respectively, of the nuclear T3 in liver and kidney, and the nuclear receptors of these tissues were about 50% saturated. Since our previous studies have shown that the occupancy of the pituitary nuclear T3 receptors may regulate TSH release, these data provide a mechanism by which TSH secretion could be altered by changes in either plasma T3 or T4, whereas nuclear T3 in liver and kidney is predominantly a function of the plasma T3 concentration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expressed in the endoplasmic reticulum (21,22), D2 generated T3 first accumulates in the cell long enough to contribute to the nuclear T 3 pool (23); thus, changes in D2 activity can cause intracrine tissue-specific changes in thyroid signaling.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [23]
Citations
Cites
An Improved Diphenylamine Method for the Estimation of Deoxyribonucleic Acid
Giles, K. W., & MYERS, A. (1965) · Nature · doi:10.1038/206093a0 · Cited by 1,934
The Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine and Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 831
Oppenheimer, J. H., Schwartz, H. L., & Surks, M. I. (1974) · Endocrinology · doi:10.1210/endo-95-3-897 · Cited by 468
SPECIFIC NUCLEAR TRIIODOTHYRONINE BINDING SITES IN RAT LIVER AND KIDNEY1
Oppenheimer, J. H., Koerner, D. R., Schwartz, H. L., & Surks, M. I. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-2-330 · Cited by 340
Silva, J. E., & Larsen, P. R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109041 · Cited by 208
Self-citationDirect immunoassay of triiodothyronine in human serum
Larsen, P. R. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107000 · Cited by 205
Self-citationSilva, J. E., & Larsen, P. R. (1977) · Science · doi:10.1126/science.199941 · Cited by 198
Self-citationLimited Binding Capacity Sites for l-Triiodothyronine in Rat Liver Nuclei
Oppenheimer, J. H., Schwartz, H. L., Koerner, D. R., & Surks, M. I. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107615 · Cited by 159
Triiodothyronine and Thyroxine in the Serum and Thyroid Glands of Iodine-Deficient Rats
Abrams, G., & Larsen, P. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107443 · Cited by 146
Self-citationWeeke, J., & Ørskov, H. (1973) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517309084359 · Cited by 140
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Self-citationCellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Larsen, P. R., Silva, J. E., & Kaplan, M. M. (1981) · Endocrine Reviews · doi:10.1210/edrv-2-1-87 · Cited by 546
Self-citationHypothalamus‐Pituitary‐Thyroid Axis
Ortiga-Carvalho, T. M., Chiamolera, M. I., Pazos-Moura, C. C., & Wondisford, F. E. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150027 · Cited by 485
Metadata
- Authors
- SILVA, J. E., DICK, T. E., & LARSEN, P. R.
- Affiliations
- Harvard University (US)
- ORCID
- DICK, T. E.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1978-10
- Volume
- 103
- Issue
- 4
- Pages
- 1196-1207
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2021534182
- Cited by
- 189
- References
- 25
- Citations by year
- 2022: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Chemical Analysis and Environmental Impact
- Keywords
- thyroid hormone deiodination, T4 to T3 conversion, anterior pituitary, liver, kidney, thyroid hormone metabolism
- MeSH terms
- Animals, Cell Nucleus, Kidney, Liver, Male, Mathematics, Pituitary Gland, Anterior, Receptors, Cell Surface, Thyroxine, Triiodothyronine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review